Table 2.

Dxys for the different scoring systems and outcomes presented for t- and p-MDS (therapy-related and primary myelodysplastic syndromes): FAB (French-American-British classification), WHO (World Health Organization classification), IPSS-R (International Prognostic Scoring System-revised), WPSS-R (WHO-based Prognostic Scoring System-revised, cipssr (cytogenetic component of the IPSS-R), number of aberrations, and primary diagnosis.

Score	Transformation free survival		Overall survival		Time to AML
	t-MDS	p-MDS	t-MDS	p-MDS	t-MDS	p-MDS
FAB	0.19	0.30	0.17	0.28	0.24	0.42
WHO	0.24	0.29	0.19	0.26	0.41	0.44
IPSS-R	0.37	0.41	0.38	0.40	0.36	0.53
WPSS-R	0.35	0.38	0.33	0.36	0.40	0.51
cipssr	0.30	0.23	0.32	0.23	0.23	0.28
Number of aberrations	0.29	0.13	0.32	0.13	0.22	0.14
Primary diagnosis	0.05	/	0.05	/	0.03	/